Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Stool vs. Serum Hepatitis B Virus DNA in Patients with Chronic Hepatitis B
Ji-Shun Zheng1, Meng-Meng Chen2, Hai-Fei Yang2
1Department of Gastroenterology and Infectious Diseases, Anhui Medical University (The Third Affiliated Hospital), Hefei, Anhui, China (mainland).
Insights
Fecal hepatitis B virus (HBV) DNA and serum HBV DNA show distinct clinical significance in chronic hepatitis B (CHB) patients. Fecal HBV DNA correlates with Enterococcus, while serum HBV DNA relates to liver enzymes and Lactobacillus.
Area of Science:
- Hepatology
- Virology
- Microbiome Research
Background:
- Serum hepatitis B virus (HBV) DNA and hepatitis B e antigen (HBeAg) levels are linked to liver function in chronic hepatitis B (CHB).
- The clinical significance of fecal HBV DNA compared to serum HBV DNA in CHB patients remains uninvestigated.
Purpose of the Study:
- To compare the clinical significance of fecal HBV DNA and serum HBV DNA in CHB patients.
- To investigate the correlation between fecal and serum HBV DNA levels and host liver function markers and intestinal microbiota.
Main Methods:
- Collected stool and serum samples from 66 CHB patients.
- Quantified fecal HBV DNA, serum HBV DNA, and intestinal microbiota DNA using real-time quantitative PCR.
- Analyzed liver function markers and HBeAg status.
Main Results:
- A positive correlation was found between fecal and serum HBV DNA (r=0.57, P=0.001).
- Fecal HBV DNA was higher in HBeAg-positive patients and negatively correlated with alkaline phosphatase (ALP) and total bilirubin (TBIL).
- Fecal HBV DNA positively correlated with Enterococcus, while serum HBV DNA negatively correlated with alanine aminotransferase (ALT), aspartate aminotransferase (AST), and Lactobacillus.
Conclusions:
- Fecal and serum HBV DNA exhibit different clinical implications in CHB patients.
- Fecal HBV DNA may be associated with alterations in Enterococcus populations.
- Serum HBV DNA is not associated with Enterococcus changes, suggesting distinct pathogenic roles.
Abstract:
BACKGROUND Serum hepatitis B virus (HBV) DNA and hepatitis B e antigen (HBeAg) liver function in patients with chronic hepatitis B (CHB) are significantly associated. A comparison of clinical significance of fecal HBV DNA and serum HBV DNA has not yet been reported. MATERIAL AND METHODS Stool and serum samples were collected from 66 patients with CHB. Fecal HBV DNA, serum HBV DNA, and intestinal microbiota DNA were detected by real-time quantitative fluorescence polymerase chain reaction (PCR). Liver function and HBeAg were analyzed. RESULTS The stool and serum HBV DNA were positively correlated (r=0.57, P=0.001). Fecal HBV DNA was higher in the HBeAg-positive group than in the HBeAg-negative group (P=0.02). Fecal HBV DNA was negatively correlated with alkaline phosphatase (ALP) (r=-0.41, P=0.001) and TBIL (r=-0.29, P=0.02), and was positively correlated with Enterococcus (r=0.38, P=0.002). Serum HBV DNA was negatively correlated with alanine aminotransferase (ALT) (r=-0.30,P=0.02), aminotransferase (AST) (r=-0.26, P=0.049), and Lactobacillus (r=-0.31, P=0.01). CONCLUSIONS These observations suggest that fecal HBV DNA and serum HBV DNA in patients with CHB have different effects. Fecal HBV DNA might be associated with changes in Enterococcus concentrations, but serum HBV DNA is not.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Serum Laboratory Studies, Stool Test, Breath Test

